Revolution Medicines revenue and financials
$199.87Change from previous close: −3.76%Absolute change: −$7.81
Fiscal year ending in December. Sources and method on the page Methodology and sources.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | 0.7 | — |
| Cost of revenue | 395 | 344 | 295 | 263 | 224 | 206 | 188 | 152 | 135 | 118 | 137 | 108 |
| Gross profit | -395 | -344 | -295 | -263 | -224 | -206 | -188 | -152 | -135 | -118 | -136 | -108 |
| Selling, general and administrative | 110 | 101 | 66.7 | 52.8 | 40.6 | 35.0 | 28.2 | 24.0 | 21.7 | 22.8 | 18.6 | 15.5 |
| Research and development | 395 | 344 | 295 | 263 | 224 | — | — | — | — | — | — | — |
| Operating income | -505 | -445 | -362 | -315 | -265 | -241 | -216 | -176 | -157 | -141 | -154 | -123 |
| EBIT | -505 | -445 | -362 | -315 | -265 | -241 | -216 | -176 | -157 | -141 | -154 | -123 |
| EBITDA | -503 | -443 | -359 | -313 | -263 | -239 | -215 | -174 | -155 | -139 | -153 | -122 |
| Interest expense | 23.8 | 12.2 | 11.9 | 11.4 | 0.9 | — | — | — | — | — | 0.3 | — |
| Pre-tax income | -644 | -454 | -365 | -305 | -248 | -213 | -195 | -156 | -133 | -116 | -161 | -112 |
| Income tax | — | — | — | — | — | — | -0.8 | — | — | — | 0.3 | -3.9 |
| Net income | -644 | -454 | -365 | -305 | -248 | -213 | -195 | -156 | -133 | -116 | -162 | -108 |
| Net income to common shareholders | -644 | -454 | -365 | -305 | -248 | -213 | -195 | -156 | -133 | -116 | -162 | -108 |
| Basic EPS | -3.06 | -2.29 | -1.86 | -1.61 | -1.31 | -1.13 | -1.12 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 |
| Diluted EPS | -3.06 | -2.29 | -1.86 | -1.61 | -1.31 | -1.13 | -1.12 | -0.94 | -0.81 | -0.70 | -1.14 | -0.99 |
| Average shares (basic) | 211 | 198 | 197 | 189 | 189 | 188 | 174 | 167 | 165 | 165 | 141 | 109 |
| Average shares (diluted) | 211 | 198 | 197 | 189 | 189 | 188 | 174 | 167 | 165 | 165 | 141 | 109 |